Navigation Links
The MedZilla Report: October 2008 Employment Outlook for Biotech/Pharma/Health
Date:12/3/2008

Despite roller-coaster changes in the U.S. and worldwide stock markets, the trend in health care employment could be counted on once again: tens of thousands of new jobs created in October, bringing yearly growth up over 345,000.The MedZilla.com Employment Report analyzes the numbers for October 2008 and announces the findings.

Seattle, WA (Vocus) December 3, 2008 -- The U.S. economy experienced some subtle and – some might say – counterintuitive shifts in October, with the stock market moving like a roller coaster and gas prices dropping to sub-$2.00 per-gallon prices. According to MedZilla.com, the leading employment and career website for biotech, pharmaceuticals, health care, science and medical device, it found that one thing unchanged is the trend in health care job creation; 26,000 new jobs were created in October, putting health care employment growth at over 348,000 for the past twelve months.

News was not all good, however; as in previous months, some health care jobs were cut. In October, the most notable shrinkage was in Minnesota and the Northeast, but even the health system that announced the largest number of employment cutbacks – Alina in Minneapolis – was not planning to actively terminate employees. Instead, according to the St. Paul Pioneer Press, they will be eliminating positions via attrition – that is, not filling openings once current employees choose to depart. The greater number of outplacements, as in previous months, looks to come from pharmaceuticals. Once again, GlaxoSmithKline announced that they would be eliminating as many as 850 research and development positions. Most pharmaceutical companies that said they had planned to lay off employees did so under cover of restructuring efforts, as they – like most if not all companies in the country – work to eliminate costs and increase productivity at the same time.
'/>"/>

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Page: 1 2 3

Related biology technology :

1. The MedZilla Report: September 2008 Employment Outlook for Biotech/Pharma/Health
2. PharmSource and BioProcess Technology Consultants Announce Publication of New Market Report: Cell Culture Manufacturing Capacity: Trends and Outlook through 2013
3. New Competitive Intelligence Speakers Spark Interest in Pharmaceutical Conference on October 1-2 in NJ
4. XTL Biopharmaceuticals Ltd. AGM / EGM Postponed Until October 2, 2007
5. Juvaris BioTherapeutics Announces Six Scientific Presentations at Infectious Diseases Society of America (IDSA) Meeting October 6, 2007
6. Mylan to Host Investor Day on October 3, 2007
7. Rosetta Genomics to Host and Webcast its R&D Day on Friday, October 26, 2007
8. Rosetta Genomics Will Host and Webcast its R&D Day on Friday, October 26, 2007
9. NPS Pharmaceuticals, Inc. Announces an Increase in Tender Offer Price for Its 3.0% Convertible Notes Due 2008 and Extends Expiration Date Until October 17, 2007
10. Biodel Inc. to Present at BIO InvestorForum 2007 Conference on October 11, 2007
11. Biodel Inc. to Present at Natixis Bleichroeder Hidden Gems Conference on October 8, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
The MedZilla Report: October 2008 Employment Outlook for Biotech/Pharma/Health
(Date:12/17/2014)... 17, 2014 Based on the ... surgical imaging market is dominated by four major ... imaging market. These players include GE Healthcare (U.K.), ... (Germany). , Full Report Copy at ... Healthcare can be attributed to its strong product ...
(Date:12/17/2014)... December 17, 2014 Ipsen Biopharmaceuticals, ... IPN; ADR: IPSEY), today announced that ... as Somatuline®) was approved by the U.S. Food ... gastroenteropancreatic neuroendocrine tumors (GEP-NETs) in adult patients with ... metastatic disease to improve progression-free survival (PFS). , ...
(Date:12/17/2014)... December 17, 2014 Xeno Diagnostics ... following its most recent COLA inspection. Xeno has ... a national healthcare accreditation organization. Accreditation is earned ... quality in day-to-day operations, demonstrate continued accuracy in ... rigorous on-site laboratory survey. , While ...
(Date:12/17/2014)... Dec. 16, 2014  Vermillion, Inc. (NASDAQ: ... disease, today announced the next step in its expanded ... solutions provider with the naming of current Chief Operating ... Executive Officer, while current Chairman of the Board and ... as Chairman. These changes are effective January 1, 2015. ...
Breaking Biology Technology:Global Refurbished Surgical Imaging Market by Product & Application is Estimated to Reach $1.25 Billion by 2019 - New Research Report by MarketsandMarkets 2Global Refurbished Surgical Imaging Market by Product & Application is Estimated to Reach $1.25 Billion by 2019 - New Research Report by MarketsandMarkets 3Global Refurbished Surgical Imaging Market by Product & Application is Estimated to Reach $1.25 Billion by 2019 - New Research Report by MarketsandMarkets 4Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 4Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 5Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 6Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 7Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 8Xeno Diagnostics Receives 3rd Award for Laboratory Excellence 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 3Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 4
... Intarcia Therapeutics, Inc. today announced that its ... to the position of Chairman, President and Chief Executive ... Executive Chairman of the Board since August 2010 and ... 20 years of leadership and global experience in building ...
... AlphaBio Centrix, a Nevada-based biotech corporation, announced this week ... This is a term used in programming wearable TheraEX ... the energy field that surrounds all life forms. ... In fact, in its basic form, it embodies seven major ...
... March 28, 2012 Marshall Hicks, M.D., FSIR, an ... imaging at the University of Texas MD Anderson Cancer ... of the Society of Interventional Radiology during its 37th ... a national organization of nearly 5,000 scientists and allied ...
Cached Biology Technology:Intarcia Announces Expanded Appointment for Kurt Graves as Chairman, President and Chief Executive Officer 2Intarcia Announces Expanded Appointment for Kurt Graves as Chairman, President and Chief Executive Officer 3Intarcia Announces Expanded Appointment for Kurt Graves as Chairman, President and Chief Executive Officer 4AlphaBio Centrix, LLC Announces a New Discovery for Programming Energetic Patches 2Society of Interventional Radiology Names Marshall Hicks, M.D., FSIR, as 2012-13 President 2Society of Interventional Radiology Names Marshall Hicks, M.D., FSIR, as 2012-13 President 3
(Date:12/15/2014)... , Dec. 12, 2014 Research and Markets ... addition of the "Global Facial Recognition Market ... http://photos.prnewswire.com/prnh/20130307/600769 Facial ... of individuals. Facial recognition system measures the overall ... jaw edges, mouth, and the distance between eyes. ...
(Date:12/10/2014)... 2014 You,ve been here before: you desperately need ... your password, site key or the answer to your secret ... teacher? Today, Hoyos Labs , a ... will finally put an end to the frustration that comes ... . 1U leverages a user,s smartphone to acquire his or ...
(Date:12/10/2014)... December 9, 2014   ... Platform   Jifflenow, ... scheduling solutions for business-to-business (B2B) events, today announced ... in mobile near-field communication (NFC), Bluetooth low energy ... (Logo: http://photos.prnewswire.com/prnh/20140612/691055) , Jifflenow will integrate ...
Breaking Biology News(10 mins):Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 2The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 3Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 2Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 3
... In a brief paper in the journal Bioinformatics ... Web-based program called Spliceman for predicting whether genetic mutations ... potentially leading to disease. "Spliceman takes a set ... likely these single nucleotide variants alter splicing phenotypes," write ...
... in German . The Fukushima ... not over yet, neither in Japan nor in Germany. ... working groups that are still processing scientific findings for ... the energy turnaround in Germany by conducting research into ...
... and the Department of Fish and Game have completed an ... species of greatest concern. This first-of-its-kind study prioritizes which species ... in California. The study was published this week in the ... the study is that our unique approach is one that ...
Cached Biology News:Will a genetic mutation cause trouble? Ask Spliceman 21 year after Fukushima 21 year after Fukushima 3New study will help protect vulnerable birds from impacts of climate change 2
albumin from bovine serum (BSA), tetramethylrhodamine conjugate...
Full service including gene cloning, protien expression and purification of 1 liter culture....
Request Info...
... Blot Processing Standard Tray (3 per ... gel staining and blot processing.Automated staining ... for proteins and nucleic acid analysis.Prepares ... and chromogenic detection.Programmable control of protocol, ...
Biology Products: